Next Article in Journal
Powering Nutrition Research: Practical Strategies for Sample Size in Multiple Regression
Previous Article in Journal
Use of Amino Acids as Supplements for Matching Nutrition, Training, and Rehabilitation—Focusing on Some Questions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synergistic Effects of MTHFR, MTRR, and MTR Gene Variants on Serum Folate Levels and Cognitive Function in Chinese Preschoolers: A Cross-Sectional Study

1
National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China
2
People’s Medical Publishing House Research Institute, Beijing 100021, China
3
Fengtai District Center for Disease Control and Prevention of Beijing Municipality, Beijing 100071, China
*
Authors to whom correspondence should be addressed.
Nutrients 2025, 17(16), 2666; https://doi.org/10.3390/nu17162666
Submission received: 4 July 2025 / Revised: 15 August 2025 / Accepted: 16 August 2025 / Published: 18 August 2025
(This article belongs to the Section Pediatric Nutrition)

Abstract

Background/Objectives: Subnormal folate levels have a detrimental impact on the growth and development of preschoolers. We aimed to investigate the association between independent/synergistic effects of the gene polymorphisms (methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms, alongside methionine synthase reductase (MTRR) A66G polymorphism and the methionine synthase (MTR) A2756G polymorphism) and serum folate levels as well as cognitive levels in Chinese preschoolers aged 5–7 years. Methods: Data were sourced from 614 children, acquired through the “Long-term Health Effects Assessment Project of Infants and Toddlers Nutritional Pack (LHEAITNP)” program were used. Folate serum concentrations were measured using a microbiologically modified technique. The genotypes of MTHFR A1298C and C677T, together with MTRR A66G, were identified by Kramer’s Allele-Specific PCR (KASP) technique. The cognitive scores of children were assessed by questionnaire. Results: MTHFR 677TT and MTR 2756AG + GG correlated negatively with serum folate levels (TT vs. CC + CT, p = 0.0009 and AG + GG vs. AA, p = 0.0057, respectively). MTHFR C677T and A1298C were independently linked to an elevated risk of suboptimal cognitive development (TT vs. CC + CT, p = 0.0009 and AA vs. CA + CC, p < 0.0001, respectively). The joint impact of these risk genotypes showed significantly increased risk of folate deficiency and inferior cognitive function compared to non-risk genotypes, particularly in those with more than two risk genotypes. The findings were corroborated by a cumulative effects model (p < 0.05). Conclusions: Our results indicate the substantial association between folate-homocysteine metabolism gene variants and serum folate status/cognitive performance in Chinese preschoolers. Potential gene-nutrient interactions worthy of longitudinal investigation.

1. Introduction

Nutrition, particularly vitamins, significantly influences neurological and physiological development from early infancy through later life [1]. Folate (Vitamin B9) is a vital water-soluble B vitamin that is a transporter of one-carbon units in the body [2]. The metabolic pathway critically regulates DNA and protein synthesis, both vital processes for cellular proliferation and differentiation [3]. Impairments in these fundamental processes may lead to growth retardation and developmental anomalies [4]. The folate cycle is an intricate biochemical mechanism strongly linked to homocysteine (Hcy) metabolism [5,6,7]. Folate affects nerve myelination [8,9], whereas Hcy accumulation resulting from folate deficiency can cause structural damage to white matter [10], both of which affect cognitive performance [11]. Longitudinal genomic analyses reveal that DNA methylation profiles undergo substantial remodeling during the initial five years of life, achieving stability by age seven [12]. DNA methylation significantly correlates with nutrients, mainly when methyl production is modulated by specific nutrients within the one-carbon metabolic pathway (folate, methionine, and B12) [13,14].
Folate is assimilated in the small intestine and transformed into dihydrofolate (DHF) and tetrahydrofolate (THF). THF is further converted to 5,10-methylenetetrahydrofolate (5,10-CH2-THF), which is then turned into 5-methyltetrahydrofolate (5-MTHF) by the enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) [15,16,17,18]. 5-MTHF functions as a methyl donor, facilitating the transfer of a methyl group to homocysteine via the enzyme 5-methyltetrahydrofolate transmethylase (MTR) to produce methionine [19,20]. The activity of MTR relies on reducing 5-methyltetrahydrofolate transmethylase reductase (MTRR) to enable the cycle’s progression [21].
Given this fundamental role of folate metabolism in cellular processes (Figure 1), we hypothesized that high-risk alleles for the single-nucleotide polymorphisms (SNPs) we studied (MTHFR C677T, MTHFR A1298C, MTRR A66G, and MTR A2756G) were correlated with suboptimal folate status/cognitive performance. However, research has examined the association between serum folate levels/cognitive performance and genetic variants, most focused on adult populations, with few studies on large samples of typical pediatric populations [22]. The impact of these polymorphisms throughout critical cognition-developmental periods (preschool age) remains unknown. To address this knowledge gap, we conducted a cross-sectional study to investigate the associations between the polymorphisms of these genes and serum folate levels/neurocognitive development.

2. Materials and Methods

2.1. Study Design

The population-based cross-sectional study was conducted in the provinces of Guizhou and Yunnan. All measurements (cognitive assessments and covariates) were acquired during a single study visit in 2023.

2.2. Research Participants

The study focused on the “Long-term Health Effects Assessment Project of Infants and Toddlers Nutritional Pack (LHEAITNP)” project. The participants were Han Chinese preschool children aged 5–7 years, all from the in-depth monitoring counties (Guiding County, Guizhou Province, and Song County, Henan Province). Figure 2 shows the detailed inclusion and exclusion criteria. A questionnaire was employed to gather fundamental information. The LHEAITNP project received approval from the Ethics Committee of the Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention (No. 2018.017). All children’s guardians provided written informed consent before answering the questionnaire and collecting the biological specimens.

2.3. Blood Sample Dispensing and Storage

Researchers collected venous blood from participants in non-fasting states using vacuum blood collection tubes, maintained the samples at room temperature for 20–30 min, and centrifuged them at 3000 r/min for 15 min to separate the serum. The supernatant was aliquoted into a freezing tube and stored at −80 °C, while the sedimented blood cells were retained in the blood collection tube and stored at −20 °C.

2.4. DNA Extraction and Genotyping

DNA was extracted from frozen blood cell pellets using magnetic beads as the solid phase for nucleic acid adsorption. The Kramer’s allele-specific PCR (KASP) method was used for genotyping. We designed the KASP primers (Table 1) for four SNPs (MTHFR C677T/A1298C, MTRR A66G, and MTR A2756G, respectively) [23].

2.5. Measurement of Serum Folate Concentration

The improved microbial assay determined serum folate by measuring the growth reaction of Lactobacillus rhamnosus [24]. The process involves (1) preparing folate casein medium (for growth/detection purposes); (2) activating and preserving the bacterial strain; (3) inoculating the activated bacteria onto the detection medium and incubating the mixture with samples in a 96-well plate at 37 °C for 42–45 h; and (4) measuring the absorbance at 590 nm and calculating the concentration using the standard curve. The main form of serum folate detected by this method is 5-MTHF, which can accurately reflect the folate nutritional status of the human body.

2.6. Evaluation of Basic Cognition

According to “Wechsler Intelligence Scale for Children (WISC)”, three sections: “Graphical Reasoning”, “Reciting Numbers in Reverse Order”, and “Decoding”, are designed to assess children’s basic cognitive ability. The three components yielded a cumulative score of 100 for the three components (Supplementary Guidance S1).

2.7. Statistical Analysis

All statistical analyses were conducted by SAS (v. 9.4) statistical software, and data visualization was performed using R 4.5.1. Based on the non-normal distribution of continuous variables (age, BMI, birth weight/height), they are presented as median and quartiles, the differences of which were assessed using the Kruskal–Wallis test. Categorical variables (gender, province, caregiver’s education level) are presented as the number of instances (n) and percentages (%), and their prevalences were compared using the χ2 test. Low folate levels are defined as serum folate levels < 6 ng/mL, and high folate levels are defined as >20 ng/mL [25]. Groups based on serum folate level thresholds enable comparison of baseline characteristics across different folate status categories. Serum folate levels and cognitive scores show a skewed distribution, so further analysis was conducted after logarithmic transformation. Hardy–Weinberg equilibrium analysis of different genes was also performed through the χ2 test.
A linear regression model assessed the relationship between the independent and combined effects of gene polymorphisms and logarithmically transformed variables. Based on the comparison of baseline characteristics, we used age, gender, and the variables (BMI, birth weight, and province), which were different among groups, as covariates in adjusting the models. A generalized linear model (GLM) was used for trend testing to validate the above results. In the results, a two-sided p < 0.05 is considered statistically significant.

3. Results

3.1. Hardy–Weinberg Equilibrium Test

Six hundred and fourteen preschool children (boys: 315, girls: 299) were included, and their anthropometric data were collected. The four polymorphisms (MTHFR C677T, MTHFR A1298C, MTRR A66G, and MTR A2756G) are all consistent with the Hardy–Weinberg equilibrium (p-values of 0.1635, 0.2339, 0.8924, and 0.0855, respectively), indicating that the study participants derived from a homogeneous Mendelian population.

3.2. Demographic and Clinical Characteristics

No substantial differences were observed in age, birth height, cognitive scores, gender, and educational level of caregivers across the three levels of serum folate. However, children with higher BMI or birth weight exhibited reduced serum folate levels (p < 0.05). Statistically significant disparities exist in serum folate levels among children from different provinces (p < 0.0001). Comparison of genotype frequencies for four SNPs across varying folate levels revealed statistically significant differences for MTHFR C677T (p < 0.0001) and MTHFR A1298C (p = 0.0234) among the three groups (Table 2).

3.3. Association Between Genotypes and Variables (Folate, Cognitive Scores)

3.3.1. Single Gene Polymorphism

Table 3 illustrates the association between MTHFR, MTRR, MTR polymorphisms, and serum folate levels, along with cognitive scores. For MTHFR C677T, the TT genotype was strongly associated with lower folate levels and cognitive scores compared to CC in analyses (adjusted βfolate = −0.0907, p = 0.0018; βscores = −0.1253, p = 0.0002). TT genotypes also showed lower folate levels and cognitive scores than combining CC + CT genotypes (adjusted βfolate = −0.1595, p = 0.0009; βscores = −0.0914, p = 0.0009). Children with MTHFR 1298AA/CA had lower cognitive scores than those with either MTHFR 1298CC genotype (Adjusted βfolate = −0.1165, p < 0.0001). No significant associations were found for MTRR A66G, while children carrying MTR 2756AG/GG genotypes had lower serum folate levels than AA (Adjusted βfolate = −0.1402, p = 0.0057).
Figure 3 illustrates the differences in serum folate/cognitive levels between genotypes and the differences in cognitive levels across serum folate subgroups. The serum folate levels and cognitive scores in individuals with the MTHFR 677TT/1298AA genotype were significantly lower (p < 0.05). Serum folate levels were lower in subjects with the MTR 2756GG + AG genotypes than those with MTR 2756AA (p < 0.05). No significant differences in cognitive performance were observed across the MTRR A66G and MTR A2756G genotype variants. Cognitive scores remained comparable across the spectrum of serum folate levels.

3.3.2. Joint Gene Polymorphisms

In joint analyses (Table 4), MTHFR 677TT/1298AA genotype carriers exhibited reduced serum folate levels and cognitive scores compared to those with MTHFR 677CC + CT/1298CC + CA (adjusted: βfolate = −0.1788, p = 0.0013; βscores = −0.1538, p < 0.0001). Furthermore, children with MTHFR 677TT/MTRR GA + AA genotypes had reduced folate levels and cognitive scores, in comparison to those with MTHFR 677CC + CT/MTRR 66GG genotypes (adjusted: βfolate = −0.2264, p = 0.0231; βscores = −0.1169, p = 0.0401). Similarly, compared with the MTHFR 677CC + CT/MTR 2756AA carriers, children with MTHFR 677TT/MTR 2756AG + GG genotypes exhibited diminished serum folate levels and cognitive scores (Adjusted: βfolate = −0.2812, p = 0.0020; βscores = −0.1253, p = 0.0165), as did MTHFR 1298AA/MTR 2756AG + GG carriers compared to 1298CC + CA/MTR 2756AA (adjusted: βfolate = −0.2172, p = 0.0017; βscores = −0.1144, p = 0.0035). No substantial interactions were identified between MTRR A66G and MTHFR A1298C/MTR A2756G.
Figure 4 demonstrates the relationship between pairwise gene combinations and serum folate levels/cognitive scores, revealing that combinations of two risk genotypes are associated with lower folate levels/cognitive performance.

3.4. Cumulative Genotypes and Serum Folate and Cognitive Scores

The correlation between cumulative risk genotypes and serum folate level/cognitive scores is shown in Table 5. In comparison to null risk genotype carriers, children possessing two (β = −0.1504, p < 0.05) or more risk genotypes (β = −0.2617, p < 0.05) had significantly lower serum folate levels. Additionally, the trend test results indicated a significant decrease in serum folate levels with an increasing quantity of risk genotypes (p < 0.05). Moreover, children’s basic cognitive scores declined as the quantity of risk genes increased (p < 0.05). Stratified analysis of folate levels indicated that children in the high folate level subgroup carrying two (β = −0.2231, p < 0.05) or more (β = −0.3644, p < 0.05) risk genotypes had reduced cognitive levels.

4. Discussion

Many studies have been conducted on folate metabolism-related SNPs. This study assessed the serum folate concentrations, basic cognitive scores, and genotypic frequencies of four SNPs in children to evaluate potential risk or interaction.
“Folates” is a broad category encompassing folic acid and its biologically active derivatives [2]. Aberrant folate metabolism is linked to various diseases [26]. A prevalent cause of megaloblastic anemia is folate insufficiency [27], which also leads to neural tube defects, cardiovascular diseases, and cognitive impairment [28,29]. Early childhood development constitutes a phase of exceptional neuroplasticity wherein cognitive, socioemotional, communicative, and motor systems undergo coordinated maturation throughout the brain’s primary growth period (0–8 years) [30]. Folate is strongly correlated with the neural cognitive development of children [31,32], so the polymorphisms of folate metabolism-related genes are relevant [33].
MTHFR, a pivotal folate metabolic enzyme, regulates circulating folate homeostasis. Its functional polymorphisms (C677T and A1298C) directly impair enzymatic activity, disrupting folate metabolism [34,35]. The T allele of the MTHFR C677T variant would reduce MTHFR activity due to increased enzyme thermolability [36]. MTHFR-mediated 5-MTHF production from 5,10-CH2-THF is compromised by the MTHFR C677T variant [37], leading to impaired homocysteine metabolism and consequent hyperhomocysteinemia [18]. Elevated homocysteine accelerates folate depletion. This study indicated that compared with MTHFR 677CC genotype carriers, children with MTHFR 677TT genotype exhibited reduced serum folate levels (p = 0.0018, Table 3) and diminished cognitive scores (p = 0.0002, Table 3), corroborated by many studies [38,39,40,41]. Furthermore, our findings showed that the synergistic effect of MTHFR 677TT and 1298AA genotype correlated with decreased cognitive scores (p < 0.0001, Table 4) and serum folate levels (p = 0.0013, Table 4), corroborating findings by Zappacosta B et al. [34], suggesting that the interaction of the two MTHFR polymorphisms significantly reflected serum folate status and may consequently impact cognitive development in children.
The A1298C variant (C allele) causes an alanine–glutamate substitution in MTHFR, disrupting the conversion of methyl tetrahydrofolate to tetrahydrobiopterin and subsequently affecting folate concentrations [42]. This study revealed a significant disparity in cognitive scores associated with different genotypes of MTHFR A1298C. Children with the MTHFR 1298AA genotype exhibited lower serum folate levels than those with the MTHFR 1298CC + CA genotype (p = 0.0866, Table 3). Also, they demonstrated lower cognitive scores (p < 0.0001, Table 3), indicating that the MTHFR 1298CC + CA genotype may be a protective factor against folate deficiency. In conjunction with studies that have obtained the same results, it is indicated that the C allele of the MTHFR 1298 polymorphism correlates with an increased risk of elevated folate concentrations, thus decreasing the risk of cognitive disorders [43,44].
MTR and MTRR are pivotal enzymes in the folate-homocysteine metabolism pathway, regulating folate cycling and methylation processes through synergistic activity [45]. A deficiency in MTRR leads to the inactivation of MTR, preventing the conversion of 5-MTHF to THF, ultimately disrupting the folate metabolic cycle and influencing nerve cell differentiation, synapse formation, and myelination [46]. In the study, the MTRR A66G polymorphism shows no significant association with serum folate levels/cognitive scores in children across GG, GA, and AA genotypes (p > 0.05, Table 3), a finding corroborated by Nasri K et al. [15]. Potential explanations for the non-significant association include a healthy dietary state obscuring the effect and inadequate statistical power of the study (limited sample size of mutant genotype GG), among others.
MTR dysfunction inhibits 5-MTHF conversion to THF, disrupting folate cycling and causing functional deficiency [47]. This study showed that children with MTR 2756AG + GG had a lower serum folate level than the others (p = 0.0057, Table 3). Conversely, research by Li W et al. [48] and Barbosa PR et al. [49] has demonstrated an increased risk of folate deficiency compared to the MTR 2756GG genotype. The joint effects of MTR A2756G and MTRR A66G polymorphisms exhibited a non-significant association with serum folate levels or cognitive performance. However, the combinations of MTHFR C677T and MTRR A66G (p < 0.05, Table 4), as well as MTHFR C677T/A1298C and MTR A2756G (p < 0.05, Table 4), exhibited significant correlations, which implied disrupted methyl flux: reduced 5-MTHF production (MTHFR defect) coupled with impaired THF regeneration (MTR defect) depleted serum folate pools [50].
The study identified the risk genotypes (MTHFR 677TT, MTHFR 1298AA, MTRR 66GA+AA, and MTR 2756AG + GG, respectively) associated with lower serum folate levels and cognitive scores. However, this study’s cognitive scores under the high folate level stratum were lower overall than those under the low folate level stratum (Figure 3b). The potential explanation for the paradoxical finding may be: (1) the potential “methyl trap” phenomenon at elevated folate concentrations may disrupt vitamin B12 metabolism and exacerbate cognitive impairment [51]; (2) serum folate levels do not accurately reflect 5-MTHF levels in neural tissue [52]. Future investigations should incorporate erythrocyte folate, B12 status, and methylation biomarkers to characterize this gene-nutrient interaction better.
Our assessment revealed that as the severity of genetic defects increases, so does the risk of serum folate deficiency/poor cognitive performance in children (p < 0.05). Subgroup analysis revealed that the higher folate level group results were consistent with the above findings (p < 0.05, Table 4). The potential cause could be that serum folate reflects recent intake, thus failing to assess actual tissue utilization appropriately.
The primary novelty of this study is its concentration on Chinese preschoolers as the study population, highlighting early-life genetic vulnerability as a key factor of serum folate variation during periods of rapid growth. However, our study has several important limitations: (1) the regional focus of the st on two provinces may limit generalizability, warranting future larger regional scale and joint economic status investigation to validate; (2) the lack of vitamin B12 assessment represents a key limitation given its metabolic interplay with folate. Future work should integrate B12 measurement, homocysteine analysis, and B12-related genetic variants for more robust evaluation.

5. Conclusions

Folate insufficiency has been consistently linked to cognitive dysfunction. Our study confirmed that the MTHFR 677TT homozygous variant was statistically associated with folate deficiency/poor cognitive performance. Notably, we observed that each combination was associated with folate levels and the cognitive function through a comprehensive analysis of polymorphic interactions between (i) MTHFR C677T and A1298C, (ii) the MTHFR C677T and MTRR A66G, (iii) the MTHFR C677T and MTR A2756G, and (iv) MTHFR A1298C and MTR A2756G. Future studies could explore the potential value of genetic screening in folate monitoring and systematically assess its translational feasibility.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu17162666/s1, Guidance S1: Guidance Manual for Primary Testers of Basic Cognitive Skills.

Author Contributions

Conceptualization, Z.G.; data curation, L.O., L.P., J.W., C.H. and X.Z.; formal analysis, L.O.; funding acquisition, Z.G. and Y.L.; investigation, J.W., C.H., X.Z., M.W. (Mengyao Wang), and M.W. (Mengtian Wang); methodology, L.P. and Y.L.; project administration, Z.G.; resources, Z.G.; visualization, Y.L.; writing—original draft, L.O.; writing—review and editing, L.O. and Y.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Study of Diet and Nutrition Assessment and Intervention Technology (No. 2020YFC2006301) from Active Health and Aging Technologic Solutions Major Project of National Key R&D Program; Long-term Health Effects Assessment Project of Infants and Toddlers Nutritional Pack (No. 131031107000200001).

Institutional Review Board Statement

The studies involving human participants were reviewed and approved by the Ethics Committee of the Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention (No. 2018-017). The Committee approved the study on 28 October 2022.

Informed Consent Statement

All child guardians provided their written informed consent, agreeing that the children can participate in this study. All methods and experiments were performed in accordance with the relevant guidelines and regulations.

Data Availability Statement

The datasets generated and analyzed during the current study are not publicly available due to participant privacy protection, but are available from the corresponding author on reasonable request.

Acknowledgments

The authors express their sincere appreciation to all the staff for performing the field work. They are also grateful to all the study participants.

Conflicts of Interest

The authors declare no competing interests.

Abbreviations

The following abbreviations are used in this manuscript:
DHFdihydrofolate
THFtetrahydrofolate
5,10-CH2-THF5,10-methylenetetrahydrofolate
5-MTHF5-methyltetrahydrofolate
MTHFR5,10-methylenetetrahydrofolate reductase
MTR5-methyltetrahydrofolate transmethylase
MTRR5-methyltetrahydrofolate transmethylase reductase
SNPsingle-nucleotide polymorphisms
LHEAITNPthe Long-term Health Effects Assessment Project of Infants and Toddlers Nutritional Pack
KASPKramer’s allele-specific PCR
K-ABCKaufman assessment battery for children
GLMgeneralized linear model

References

  1. McGarel, C.; Pentieva, K.; Strain, J.J.; McNulty, H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc. Nutr. Soc. 2015, 74, 46–55. [Google Scholar] [CrossRef]
  2. Shulpekova, Y.; Nechaev, V.; Kardasheva, S.; Sedova, A.; Kurbatova, A.; Bueverova, E.; Kopylov, A.; Malsagova, K.; Dlamini, J.C.; Ivashkin, V. The Concept of Folic Acid in Health and Disease. Molecules 2021, 26, 3731. [Google Scholar] [CrossRef] [PubMed]
  3. Sobczyńska-Malefora, A.; Harrington, D.J. Laboratory assessment of folate (vitamin B9) status. J. Clin. Pathol. 2018, 71, 949–956. [Google Scholar] [CrossRef] [PubMed]
  4. Naninck, E.F.G.; Stijger, P.C.; Brouwer-Brolsma, E.M. The Importance of Maternal Folate Status for Brain Development and Function of Offspring. Adv. Nutr. 2019, 10, 502–519. [Google Scholar] [CrossRef]
  5. Hiraoka, M.; Kagawa, Y. Genetic polymorphisms and folate status. Congenit. Anom. 2017, 57, 142–149. [Google Scholar] [CrossRef]
  6. Li, W.X.; Dai, S.X.; Zheng, J.J.; Liu, J.Q.; Huang, J.F. Homocysteine Metabolism Gene Polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) Jointly Elevate the Risk of Folate Deficiency. Nutrients 2015, 7, 6670–6687. [Google Scholar] [CrossRef]
  7. Mazokopakis, E.E.; Papadomanolaki, M.G.; Papadakis, J.A. Association of methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms with serum folate, cobalanin and homocysteine concentrations in Greek adults. Scand. J. Clin. Lab. Investig. 2023, 83, 69–73. [Google Scholar] [CrossRef]
  8. Zhang, L.; Xue, Z.; Liu, Q.; Liu, Y.; Xi, S.; Cheng, Y.; Li, J.; Yan, J.; Shen, Y.; Xiao, C.; et al. Disrupted folate metabolism with anesthesia leads to myelination deficits mediated by epigenetic regulation of ERMN. EBioMedicine 2019, 43, 473–486. [Google Scholar] [CrossRef]
  9. Schoendorfer, N.C.; Obeid, R.; Moxon Lester, L.; Sharp, N.; Vitetta, L.; Boyd, R.N.; Davies, P.S.W. Methylation capacity in children with severe cerebral palsy. Eur. J. Clin. Investig. 2012, 42, 768–776. [Google Scholar] [CrossRef]
  10. Tu, M.; Chung, H.; Hsu, Y.; Yang, J.; Wu, W. Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia. J. Alzheimers Dis. 2023, 96, 1329–1338. [Google Scholar] [CrossRef]
  11. Chen, B.; Linke, A.; Olson, L.; Kohli, J.; Kinnear, M.; Sereno, M.; Müller, R.A.; Carper, R.; Fishman, I. Cortical myelination in toddlers and preschoolers with autism spectrum disorder. Dev. Neurobiol. 2022, 82, 261–274. [Google Scholar] [CrossRef] [PubMed]
  12. Simpkin, A.J.; Suderman, M.; Gaunt, T.R.; Lyttleton, O.; McArdle, W.L.; Ring, S.M.; Tilling, K.; Davey Smith, G.; Relton, C.L. Longitudinal analysis of DNA methylation associated with birth weight and gestational age. Hum. Mol. Genet. 2015, 24, 3752–3763. [Google Scholar] [CrossRef]
  13. Anderson, O.S.; Sant, K.E.; Dolinoy, D.C. Nutrition and epigenetics: An interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J. Nutr. Biochem. 2012, 23, 853–859. [Google Scholar] [CrossRef]
  14. Taylor, R.M.; Smith, R.; Collins, C.E.; Evans, T.; Hure, A.J. Dietary intake and food sources of one-carbon metabolism nutrients in preschool aged children. Eur. J. Clin. Nutr. 2019, 73, 1179–1193. [Google Scholar] [CrossRef]
  15. Nasri, K.; Midani, F.; Kallel, A.; Ben Jemaa, N.; Aloui, M.; Boulares, M.; Lassoued, M.; Ben Halima, M.; Ben Wafi, S.; Soussi, M.; et al. Association of MTHFR C677T, MTHFR A1298C, and MTRR A66G Polymorphisms with Neural Tube Defects in Tunisian Parents. Pathobiology 2019, 86, 190–200. [Google Scholar] [CrossRef] [PubMed]
  16. Shi, Y.; Zhang, Z.; Wang, B.; Wang, Y.; Kong, X.; Sun, Y.; Li, A.; Cui, Y.; Zhang, Y.; Li, J.; et al. Effect of plateletcrit and methylenetetrahydrofolate reductase (MTHFR) C677T genotypes on folic acid efficacy in stroke prevention. Signal Transduct. Target. Ther. 2024, 9, 110. [Google Scholar] [CrossRef]
  17. Raghubeer, S.; Matsha, T.E. Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks. Nutrients 2021, 13, 4562. [Google Scholar] [CrossRef]
  18. Liew, S.; Gupta, E.D. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: Epidemiology, metabolism and the associated diseases. Eur. J. Med. Genet. 2015, 58, 1–10. [Google Scholar] [CrossRef]
  19. Kumari, R.; Kumar, S.; Thakur, V.K.; Singh, K.; Kumar, U. MTHFR C677T and MTR A2756G Gene Polymorphism in Neural Tube Defect Patients and Its Association with Red Blood Cell Folate Level in Eastern Indian Population. J. Indian Assoc. Pediatr. Surg. 2022, 27, 699–706. [Google Scholar] [CrossRef]
  20. Hsueh, Y.; Lin, Y.; Chung, C.; Huang, Y.; Hsieh, R.; Huang, P.; Wu, M.; Shiue, H.; Chien, S.; Lee, C.; et al. Combined effect of polymorphisms of MTHFR and MTR and arsenic methylation capacity on developmental delay in preschool children in Taiwan. Arch. Toxicol. 2020, 94, 2027–2038. [Google Scholar] [CrossRef]
  21. González-Mercado, M.G.; Rivas, F.; Gallegos-Arreola, M.P.; Morán-Moguel, M.C.; Salazar-Páramo, M.; González-López, L.; Gámez-Nava, J.I.; Muñoz-Valle, J.F.; Medina-Coss, Y.; León, R.; et al. MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate. Genet. Test. Mol. Biomark. 2017, 21, 698–704. [Google Scholar] [CrossRef]
  22. Li, W.; Cheng, F.; Zhang, A.; Dai, S.; Li, G.; Lv, W.; Zhou, T.; Zhang, Q.; Zhang, H.; Zhang, T.; et al. Folate Deficiency and Gene Polymorphisms of MTHFR, MTR and MTRR Elevate the Hyperhomocysteinemia Risk. Clin. Lab. 2017, 63, 523–533. [Google Scholar] [CrossRef]
  23. He, C.; Holme, J.; Anthony, J. SNP genotyping: The KASP assay. Methods Mol Biol. 2014, 1145, 75–86. [Google Scholar] [CrossRef] [PubMed]
  24. Li, Y.; Wang, Z.; Mao, H.M.; Wang, J.B.; Gong, W.Y.; Chen, C.; Shi, L.L.; Sun, J.; Huo, J.S. A comparative study on the detection of serum folate by microbiological assay and electrochemiluminescence immunoassay. J. Hyg. 2021, 50, 111–115. [Google Scholar] [CrossRef]
  25. World Health Organization. Serum and Red Blood Cell Folate Concentrations for Assessing Folate Status in Populations; World Health Organization: Geneva, Switzerland, 2015. [Google Scholar]
  26. Zheng, Y.; Cantley, L.C. Toward a better understanding of folate metabolism in health and disease. J. Exp. Med. 2019, 216, 253–266. [Google Scholar] [CrossRef] [PubMed]
  27. Socha, D.S.; DeSouza, S.I.; Flagg, A.; Sekeres, M.; Rogers, H.J. Severe megaloblastic anemia: Vitamin deficiency and other causes. Cleve. Clin. J. Med. 2020, 87, 153–164. [Google Scholar] [CrossRef]
  28. Balashova, O.A.; Visina, O.; Borodinsky, L.N. Folate action in nervous system development and disease. Dev. Neurobiol. 2018, 78, 391–402. [Google Scholar] [CrossRef]
  29. Elizabeth, K.E.; Praveen, S.L.; Preethi, N.R.; Jissa, V.T.; Pillai, M.R. Folate, vitamin B12, homocysteine and polymorphisms in folate metabolizing genes in children with congenital heart disease and their mothers. Eur. J. Clin. Nutr. 2017, 71, 1437–1441. [Google Scholar] [CrossRef]
  30. Chang, R.; Wei, M.; Li, C.; Jiang, Y.; Zhang, J. Association between epigenome-wide DNA methylation changes and early neurodevelopment in preschool children: Evidence from a former impoverished county in Central China. Gene 2025, 945, 149275. [Google Scholar] [CrossRef]
  31. Caffrey, A.; McNulty, H.; Rollins, M.; Prasad, G.; Gaur, P.; Talcott, J.B.; Witton, C.; Cassidy, T.; Marshall, B.; Dornan, J.; et al. Effects of maternal folic acid supplementation during the second and third trimesters of pregnancy on neurocognitive development in the child: An 11-year follow-up from a randomised controlled trial. BMC Med. 2021, 19, 73. [Google Scholar] [CrossRef]
  32. McNulty, H.; Rollins, M.; Cassidy, T.; Caffrey, A.; Marshall, B.; Dornan, J.; McLaughlin, M.; McNulty, B.A.; Ward, M.; Strain, J.J.; et al. Effect of continued folic acid supplementation beyond the first trimester of pregnancy on cognitive performance in the child: A follow-up study from a randomized controlled trial (FASSTT Offspring Trial). BMC Med. 2019, 17, 196. [Google Scholar] [CrossRef]
  33. Wang, Y.; Liu, Y.; Ji, W.; Qin, H.; Wu, H.; Xu, D.; Tukebai, T.; Wang, Z. Analysis of MTR and MTRR Polymorphisms for Neural Tube Defects Risk Association. Medicine 2015, 94, e1367. [Google Scholar] [CrossRef]
  34. Zappacosta, B.; Graziano, M.; Persichilli, S.; Di Castelnuovo, A.; Mastroiacovo, P.; Iacoviello, L. 5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: Genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults. Cell Biochem. Funct. 2014, 32, 1–4. [Google Scholar] [CrossRef]
  35. Shivkar, R.R.; Gawade, G.C.; Padwal, M.K.; Diwan, A.G.; Mahajan, S.A.; Kadam, C.Y. Association of MTHFR C677T (rs1801133) and A1298C (rs1801131) Polymorphisms with Serum Homocysteine, Folate and Vitamin B12 in Patients with Young Coronary Artery Disease. Indian J. Clin. Biochem. 2022, 37, 224–231. [Google Scholar] [CrossRef]
  36. Stanger, O.; Herrmann, W.; Pietrzik, K.; Fowler, B.; Geisel, J.; Dierkes, J.; Weger, M.; DACH-LIGA, H.E.V. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: Guidelines and recommendations. Clin. Chem. Lab. Med. 2003, 41, 1392. [Google Scholar] [CrossRef]
  37. Ye, M.; Xu, G.; Zhang, L.; Kong, Z.; Qiu, Z. Meta Analysis of Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and its association with folate and colorectal cancer. BMC Cancer 2025, 25, 169. [Google Scholar] [CrossRef]
  38. Lisboa, J.V.D.C.; Ribeiro, M.R.; Luna, R.C.P.; Lima, R.P.A.; Do Nascimento, R.A.F.; Monteiro, M.G.C.A.; Lima, K.Q.D.F.; Fechine, C.P.N.D.; de Oliveira, N.F.P.; Persuhn, D.C.; et al. Food Intervention with Folate Reduces TNF-α and Interleukin Levels in Overweight and Obese Women with the MTHFR C677T Polymorphism: A Randomized Trial. Nutrients 2020, 12, 361. [Google Scholar] [CrossRef]
  39. Obeid, R.; Warnke, I.; Wittke, A.; Bendik, I.; Troesch, B.; Schoop, R.; Hecht, C.; Demmelmair, J.; Koletzko, B. Infant blood concentrations of folate markers and catabolites are modified by 5,10-methylenetetrahydrofolate reductase C677T genotype and dietary folate source. Am. J. Clin. Nutr. 2023, 117, 509–517. [Google Scholar] [CrossRef]
  40. Qin, X.; Spence, J.D.; Li, J.; Zhang, Y.; Li, Y.; Sun, N.; Liang, M.; Song, Y.; Zhang, Y.; Wang, B.; et al. Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke. Neurology 2020, 94, e1126–e1136. [Google Scholar] [CrossRef]
  41. El-baz, F.; Abd El-Aal, M.; Moustafa Kamal, T.; Abdrabou Sadek, A.; Othman, A.A. Study of the C677T and 1298AC polymorphic genotypes of MTHFR Gene in autism spectrum disorder. Electron. Physician 2017, 9, 5287–5293. [Google Scholar] [CrossRef]
  42. Xin, Y.; Wu, L.; Lu, X.; Shangguan, S.; Wang, Z.; Chang, S.; Yin, J.; Piao, W.; Zhang, T.; Wang, L. Effects of MTHFR A1298C polymorphism on peripheral blood folate concentration in healthy populations: A meta-analysis of observational studies. Asia Pac. J. Clin. Nutr. 2018, 27, 718–727. [Google Scholar] [CrossRef] [PubMed]
  43. Safarinejad, M.R.; Shafiei, N.; Safarinejad, S. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: A case–control study. Prostate 2010, 70, 1645–1657. [Google Scholar] [CrossRef] [PubMed]
  44. Pu, D.; Shen, Y.; Wu, J. Association betweenMTHFR Gene Polymorphisms and the Risk of Autism Spectrum Disorders: AM eta-Analysis. Autism Res. 2013, 6, 384–392. [Google Scholar] [CrossRef]
  45. Leclerc, D.; Wilson, A.; Dumas, R.; Gafuik, C.; Song, D.; Watkins, D.; Heng, H.H.; Rommens, J.M.; Scherer, S.W.; Rosenblatt, D.S.; et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc. Natl. Acad. Sci. USA 1998, 95, 3059–3064. [Google Scholar] [CrossRef] [PubMed]
  46. Peng, Q.; Liao, S.; He, Y.; Liang, L.; Su, X.; Rao, C.; Li, W.; Li, S.; Lu, X. A molecular-beacon-based asymmetric PCR assay for detecting polymorphisms related to folate metabolism. J. Clin. Lab. Anal. 2020, 34, e23337. [Google Scholar] [CrossRef]
  47. Selhub, J.; Jacques, P.F.; Dallal, G.; Choumenkovitch, S.; Rogers, G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food Nutr. Bull. 2008, 29, S67–S73. [Google Scholar] [CrossRef]
  48. Li, W.; Lv, W.; Dai, S.; Pan, M.; Huang, J. Joint associations of folate, homocysteine and MTHFR, MTR and MTRR gene polymorphisms with dyslipidemia in a Chinese hypertensive population: A cross-sectional study. Lipids Health Dis. 2015, 14, 101. [Google Scholar] [CrossRef]
  49. Barbosa, P.R.; Stable, S.P.; Machado, A.L.K.; Braga, R.C.; Hirata, R.D.C.; Hirata, M.H.; Sampaio-Neto, L.F.; Allen, R.H.; Guerra-Shinohara, E.M. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur. J. Clin. Nutr. 2008, 62, 1010–1021. [Google Scholar] [CrossRef]
  50. Jackson, M.D.; Tulloch-Reid, M.K.; McFarlane-Anderson, N.; Watson, A.; Seers, V.; Bennett, F.I.; Egleston, B.; Ragin, C. Complex interaction between serum folate levels and genetic polymorphisms in folate pathway genes: Biomarkers of prostate cancer aggressiveness. Genes Nutr. 2013, 8, 199–207. [Google Scholar] [CrossRef]
  51. Miller, J.W.; Smith, A.; Troen, A.M.; Mason, J.B.; Jacques, P.F.; Selhub, J. Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications? Food Nutr. Bull. 2024, 45, S67–S72. [Google Scholar] [CrossRef]
  52. Nemati, H.; Boroujeni, A.F.; Inaloo, S.; Katibeh, P.; Shahriari, M. The Cerebrospinal Fluid Concentration of Methyltetrahydrofolate and Serum Folate in Children with Developmental Delay, Regression, and/or Refractory Epilepsy. Neurol. India 2021, 69, 1343–1348. [Google Scholar] [CrossRef]
Figure 1. Association mechanism between gene–folate metabolic pathway and cognitive function.
Figure 1. Association mechanism between gene–folate metabolic pathway and cognitive function.
Nutrients 17 02666 g001
Figure 2. Inclusion and exclusion of study participants.
Figure 2. Inclusion and exclusion of study participants.
Nutrients 17 02666 g002
Figure 3. Association analysis between gene variants, serum folate levels, and cognitive scores. (a) single gene and folate/cognition; (b) folate and cognition. * p < 0.05.
Figure 3. Association analysis between gene variants, serum folate levels, and cognitive scores. (a) single gene and folate/cognition; (b) folate and cognition. * p < 0.05.
Nutrients 17 02666 g003
Figure 4. Logarithmic serum folate levels/cognitive scores by combined genotypes. (a) combined genotypes and folate; (b) combined genotypes and cognition.
Figure 4. Logarithmic serum folate levels/cognitive scores by combined genotypes. (a) combined genotypes and folate; (b) combined genotypes and cognition.
Nutrients 17 02666 g004
Table 1. KASP primers for four SNPs.
Table 1. KASP primers for four SNPs.
SNPPrimer FAMPrimer HEXUniversal Primers
MTHFR C677TGCTCCGTCATGATGAAATCGGGCTGCGTCATCATCAAATCGACTGACCTGAACCACTTGAAGGA
MTHFR A1298CGGAGGAGCTGACCAGTCAAGAGGAGGAGCTGACCAGTGAAGCGGTAAAGAACGAAGACTTCAAAGACACTT
MTRR A66GGGCAAAGGCCATCGCAGAAGAAATAGGCAAAGGCCATCGCAGAAGAAATGTGAAGATCTGCAGAAAATCCATGTACC
MTR A2756GCCTTGAGAGACTCATAATGGCCCTTGAGAGACTCATAATGGTCTTTGAGGAAATCATCGAAGAA
Table 2. Sociodemographic and epidemiologic characteristics of the preschool children.
Table 2. Sociodemographic and epidemiologic characteristics of the preschool children.
Variables Serum Folate Level a p-Value b
Low (n = 59)Medium (n = 453)High (n = 102)
M (q1–q3) or n (%)M (q1–q3) or n (%)M (q1–q3) or n (%)
Age (months)72 (68–77)72 (68–77)72 (68–77)0.4279
BMI14.9 (14.2–16.5)14.5 (13.7–15.6)14.4 (13.5–15.3)0.0051
Birth weight (g)3350 (3030–3800)3245 (3000–3550)3200 (3000–3400)0.0496
Birth height (cm)50 (50–51)50 (50–50)50 (50–50)0.1447
Cognitive scores49 (40–53)44 (35–52)43 (34–52)0.0805
serum folate level (ng/mL)5.1 (4.4–5.4)11.3 (8.6–14.3)23.6 (21.8–26.6)<0.0001
GenderMale37 (62.71)233 (51.43)45 (44.12)0.0748
Female22 (37.29)220 (48.57)57 (55.88)
ProvinceHenan Province45 (76.27)246 (54.30)27 (26.47)<0.0001
Guizhou Province14 (23.73)207 (45.70)75 (73.53)
Educational level of caregiversPrimary school or below16 (27.12)134 (29.58)33 (32.35)0.9690
Junior high school32 (54.24)238 (52.54)51 (50.00)
High school or above11 (18.64)81 (17.88)18 (17.65)
MTHFR C677TCC6 (10.17)127 (28.04)37 (36.27)<0.0001
CT25 (42.37)215 (47.46)52 (50.98)
TT28 (47.46)111 (24.50)13 (12.75)
MTHFR A1298CCC1 (1.69)20 (4.42)6 (5.88)0.0234
CA11 (18.64)126 (27.81)40 (39.22)
AA47 (79.66)307 (67.77)56 (54.90)
MTRR A66GGG3 (5.08)31 (6.84)5 (4.90)0.3982
GA26 (44.07)162 (35.76)46 (45.10)
AA30 (50.85)260 (57.40)51 (50.00)
MTR A2756GAA47 (79.66)370 (81.68)84 (82.35)0.3706
AG10 (16.95)78 (17.22)15 (14.71)
GG2 (3.39)5 (1.10)3 (2.94)
a Serum folate levels subgroup criteria: low: <6 ng/mL; medium: 6–20 ng/mL; high: >20 ng/mL; b Kruskal–Wallis or Pearson χ2 tests were used to examine differences in continuous variables and in proportions, respectively, between serum folate status groups.
Table 3. Associations of gene polymorphisms with serum folate level/cognitive scores.
Table 3. Associations of gene polymorphisms with serum folate level/cognitive scores.
Variablesn (%)Adjusted β (95%CI) a,bAdjusted β (95%CI) a,b
MTHFR C677TCC170 (27.69)referencereference
CT292 (47.56)−0.0318 (−0.1250, 0.0615)−0.0491 (−0.1023, 0.0041) +
TT152 (24.76)−0.0907 (−0.1476, −0.0338) *−0.1253 (−0.1903, −0.0604) **
CC + CT462 (75.24)referencereference
TT152 (24.76)−0.1595 (−0.2533, −0.0656) **−0.0914 (−0.1451, −0.0377) **
MTHFR A1298CCC27 (4.40)referencereference
CA177 (28.83)0.0484 (−0.1512, 0.2480)−0.0114 (−0.1237, 0.1009)
AA410 (66.78)−0.0154 (−0.1116, 0.0809)−0.1264 (−0.2347, −0.0181) *
CC + CA204 (33.22)referencereference
AA410 (66.78)−0.0728 (−0.1560, 0.0105) +−0.1165 (−0.1633, −0.0670) **
MTRR A66GGG39 (6.35)referencereference
GA234 (38.11)−0.0497 (−0.2164, 0.1169)−0.0211 (−0.1162, 0.0740)
AA341 (55.54)−0.0216 (−0.1033, 0.0600)−0.0572 (−0.1503, 0.0360)
GG39 (6.35)referencereference
GA + AA575 (93.65)−0.0460 (−0.2055, 0.1136)−0.0422 (−0.1334, 0.0490)
MTR A2756GAA501 (81.60)referencereference
AG103 (16.78)−0.1329 (−0.2360, −0.0298) *0.0264 (−0.0329, 0.0857)
GG10 (1.63)−0.2162 (−0.5201, 0.0877)−0.0440 (−0.2188, 0.1308)
AA501 (81.60)referencereference
AG + GG113 (18.40)−0.1402 (−0.2395, −0.0410) *0.0202 (−0.0369, 0.0773)
a. Adjusted for age, gender, BMI, birth weight, and province; b. A linear regression model was employed to assess the relationship; +: 0.05 < p < 0.1; *: 0.001 < p < 0.05; **: p ≤ 0.001.
Table 4. Associations of joint gene polymorphisms with serum folate level/cognitive scores.
Table 4. Associations of joint gene polymorphisms with serum folate level/cognitive scores.
Variablesn (%)Folate-Adjusted β (95%CI) a,bCognition-Adjusted β (95%CI) a,b
MTHFR C677TMTHFR A1298C
CC + CTCC + CA200 (32.57)referencereference
CC + CTAA262 (42.67)−0.0177 (−0.1070, 0.0717)−0.1001 (−0.1506, −0.0495) **
TTCC + CA4 (0.65)0.1649 (−0.3158, 0.6456)−0.0325 (−0.3044, 0.2393)
TTAA148 (24.10)−0.1788 (−0.2872, −0.0704) *−0.1538 (−0.2151, −0.0924) **
MTHFR C677TMTRR A66G
CC + CTGG30 (4.89)referencereference
CC + CTGA + AA432 (70.36)−0.0739 (−0.2542, 0.10664)−0.0202 (−0.1232, 0.0828)
TTGG9 (1.47)−0.2754 (−0.6398, 0.0890)−0.0026 (−0.2109, 0.2057)
TTGA + AA143 (23.29)−0.2264 (−0.4216, −0.0313) *−0.1169 (−0.2284, −0.0053) *
MTHFR C677TMTR A2756G
CC + CTAA380 (61.89)referencereference
CC + CTAG + GG82 (13.36)−0.1380 (−0.2531, −0.0229) *0.0523 (−0.0137, 0.1184)
TTAA121 (19.71)−0.1576 (−0.2613, −0.0540) *−0.0708 (−0.1303, −0.0113) *
TTAG + GG31 (5.05)−0.2812 (−0.4595, −0.1028) *−0.1253 (−0.2276, −0.0230) *
MTHFR A1298CMTRR A66G
CC + CAGG9 (1.47)referencereference
CC + CAGA + AA195 (31.76)−0.1806 (−0.5072, 0.1460)0.0290 (−0.1545, 0.2124)
AAGG30 (4.89)−0.2312 (−0.5942, 0.1318)−0.0138 (−0.2177, 0.1901)
AAGA + AA380 (61.89)−0.2466 (−0.5701, 0.0770)−0.0948 (0.2765, 0.0869)
MTHFR A1298CMTR A2756G
CC + CAAA163 (26.55)referencereference
CC + CAAG + GG41 (6.68)−0.1548 (−0.3211, 0.0115) +0.0707 (−0.233, 0.1646)
AAAA338 (55.05)−0.0802 (−0.1721, 0.0118) +−0.0996 (−0.1516, −0.0477) **
AAAG + GG72 (11.73)−0.2172 (−0.3528, −0.0815) *−0.1144 (−0.1911, −0.0378) *
MTRR A66GMTR A2756G
GGAA34 (5.54)referencereference
GGAG + GG5 (0.81)0.2607 (−0.1959, 0.7172)−0.0129 (−0.2760, 0.2503)
GA + AAAA467 (76.06)0.0195 (−0.1508, 0.1898)−0.0485 (−0.1466, 0.0497)
GA + AAAG + GG108 (17.59)−0.1406 (−0.3280, 0.0468)−0.0253 (−0.1333, 0.0827)
a. Adjusted for age, gender, BMI, birth weight, and province; b. A linear regression model was employed to assess the relationship; +: 0.05 < p < 0.1; *: 0.001< p < 0.05; **: p ≤ 0.001.
Table 5. Relationship between the number of risk genotypes and serum folate/cognitive scores.
Table 5. Relationship between the number of risk genotypes and serum folate/cognitive scores.
Number of Risk Genotypes aTotal (n = 614)Serum Folate Level
Folate-β (95%CI) b,cCognition-β (95%CI) b,cLow and Medium (n = 512)High (n = 102)
Cognition-β (95%CI) b,cCognition-β (95%CI) b,c
0 (n = 154)referencereferencereferencereference
1 (n = 247)−0.0373 (−0.1349, 0.0604)−0.0620 (−0.1178, −0.0061) *−0.0567 (−0.1178, 0.0044) +−0.0966 (−0.2405, 0.0474)
2 (n = 172)−0.1504 (−0.2583, 0.0425) *−0.1049 (−0.1666, −0.0431) **−0.0899 (−0.1557, −0.0241) *−0.2231 (−0.4119, −0.0343) *
3 (n = 41)−0.2617 (−0.4312, 0.0921) *−0.1351 (−0.2321, −0.0381) *−0.1019 (−0.2041, 0.0003) +−0.3644 (−0.6750, −0.0539) *
a. Risk genotypes were defined as MTHFR 677TT, MTHFR 1298AA, MTRR 66 GA + AA, and MTR 2756AG + GG; b. Adjusted for age, gender, BMI, birth weight, and province; c. A linear regression model was employed to assess the relationship. +: 0.05 < p < 0.1; *: 0.001 < p < 0.05; **: p ≤ 0.001.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ou, L.; Peng, L.; Wang, J.; Han, C.; Zhao, X.; Wang, M.; Wang, M.; Gong, Z.; Li, Y. Synergistic Effects of MTHFR, MTRR, and MTR Gene Variants on Serum Folate Levels and Cognitive Function in Chinese Preschoolers: A Cross-Sectional Study. Nutrients 2025, 17, 2666. https://doi.org/10.3390/nu17162666

AMA Style

Ou L, Peng L, Wang J, Han C, Zhao X, Wang M, Wang M, Gong Z, Li Y. Synergistic Effects of MTHFR, MTRR, and MTR Gene Variants on Serum Folate Levels and Cognitive Function in Chinese Preschoolers: A Cross-Sectional Study. Nutrients. 2025; 17(16):2666. https://doi.org/10.3390/nu17162666

Chicago/Turabian Style

Ou, Lingling, Luolan Peng, Jingbo Wang, Chao Han, Xiayu Zhao, Mengyao Wang, Mengtian Wang, Zhaolong Gong, and Yan Li. 2025. "Synergistic Effects of MTHFR, MTRR, and MTR Gene Variants on Serum Folate Levels and Cognitive Function in Chinese Preschoolers: A Cross-Sectional Study" Nutrients 17, no. 16: 2666. https://doi.org/10.3390/nu17162666

APA Style

Ou, L., Peng, L., Wang, J., Han, C., Zhao, X., Wang, M., Wang, M., Gong, Z., & Li, Y. (2025). Synergistic Effects of MTHFR, MTRR, and MTR Gene Variants on Serum Folate Levels and Cognitive Function in Chinese Preschoolers: A Cross-Sectional Study. Nutrients, 17(16), 2666. https://doi.org/10.3390/nu17162666

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop